As of June 15, 2025, PW Medtech Group Ltd (1358.HK) reports a ROA (Return on Assets) of 2.92%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of PW Medtech Group Ltd's ROA (Return on Assets)
Over recent years, PW Medtech Group Ltd's ROA (Return on Assets) has shown significant volatility. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | 2.92% |
| 2023-12-31 | 2.97% |
| 2022-12-31 | 2.13% |
| 2021-12-31 | 18.88% |
| 2020-12-31 | 11.96% |
This slight upward trend highlights how PW Medtech Group Ltd manages its efficiency in using assets to generate earnings over time.
Comparing PW Medtech Group Ltd's ROA (Return on Assets) to Peers
To better understand PW Medtech Group Ltd's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| PW Medtech Group Ltd (1358.HK) | 2.92% |
| Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) | 18.40% |
| Shenzhen Lifotronic Technology Co Ltd (688389.SS) | 11.93% |
| Chison Medical Technologies Co Ltd (688358.SS) | 8.80% |
| AK Medical Holdings Ltd (1789.HK) | 8.21% |
| Edan Instruments Inc (300206.SZ) | 6.76% |
Compared to its competitors, PW Medtech Group Ltd's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.